ArticleJournal of translational medicine2025

Targeting lncRNA MALAT1 attenuates lenalidomide resistance via CD38 epigenetic modulation, oxidative stress-mediated cell death, and remodeling of the pro-tumor microenvironment in multiple myeloma.

Wen-Hsin Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.